Antimicrobial Resistance and Molecular Epidemiology of Corynebacterium striatum Isolated in a Tertiary Hospital in Turkey
dc.authorid | OTLU, BARIS/0000-0002-6220-0521 | |
dc.authorwosid | OTLU, BARIS/ABI-5532-2020 | |
dc.contributor.author | Asgin, Nergis | |
dc.contributor.author | Otlu, Baris | |
dc.date.accessioned | 2024-08-04T20:47:08Z | |
dc.date.available | 2024-08-04T20:47:08Z | |
dc.date.issued | 2020 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Although Corynebacterium striatum is part of the human flora, it has recently drawn attention both for its multidrug resistance and its role as an invasive infection/outbreak agent. This cross-sectional study aimed to determine the antimicrobial resistance and clonal relationships among C. striatum strains. In total, 81 C. striatum strains were identified using Phoenix-100(TM) (BD, Sparks, MD, USA). The antimicrobial resistance of the strains was determined using the Kirby-Bauer disk diffusion method. Clonal relatedness among the strains was performed via arbitrarily primed polymerase chain reaction (AP-PCR). All 81 C. striatum strains were resistant to penicillin, cefotaxime, ciprofloxacin, and tetracycline, but susceptible to vancomycin and linezolid. The resistance rates to gentamicin, erythromycin, and clindamycin were 34.6%, 79%, and 87.7% respectively. AP-PCR results showed no predominant clone among the C. striatum strains. Corynebacterium striatum is reportedly the cause of an increasing number of invasive infections/outbreaks. Moreover, treatment options are limited. The study showed that vancomycin, linezolid, and gentamicin can be selected for the empirical treatment of C. striatum infections. Although no single-clone outbreak was observed in our hospital, small clonal circulations were observed within some units, indicating cross-contamination. Therefore, a comprehensive infection control program is warranted in future. | en_US |
dc.identifier.doi | 10.3390/pathogens9020136 | |
dc.identifier.issn | 2076-0817 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 32093060 | en_US |
dc.identifier.scopus | 2-s2.0-85079705767 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.3390/pathogens9020136 | |
dc.identifier.uri | https://hdl.handle.net/11616/99187 | |
dc.identifier.volume | 9 | en_US |
dc.identifier.wos | WOS:000519242900024 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mdpi | en_US |
dc.relation.ispartof | Pathogens | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | antimicrobial resistance | en_US |
dc.subject | arbitrarily primed polymerase chain reaction | en_US |
dc.subject | clone | en_US |
dc.subject | Corynebacterium striatum | en_US |
dc.subject | molecular epidemiology | en_US |
dc.subject | nosocomial outbreak | en_US |
dc.title | Antimicrobial Resistance and Molecular Epidemiology of Corynebacterium striatum Isolated in a Tertiary Hospital in Turkey | en_US |
dc.type | Article | en_US |